745 related articles for article (PubMed ID: 15885353)
1. Evaluation of the increase in model for end-stage liver disease (DeltaMELD) score over time as a prognostic predictor in patients with advanced cirrhosis: risk factor analysis and comparison with initial MELD and Child-Turcotte-Pugh score.
Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
J Hepatol; 2005 Jun; 42(6):826-32. PubMed ID: 15885353
[TBL] [Abstract][Full Text] [Related]
2. [Usefulness of DeltaMELD/month for prediction of the mortality in the first episode of variceal bleeding patients with liver cirrhosis: comparison with CTP, MELD score and DeltaCTP/month].
Bae WK; Lee JS; Kim NH; Kim KA; Moon YS; Oh MK
Korean J Hepatol; 2007 Mar; 13(1):51-60. PubMed ID: 17380075
[TBL] [Abstract][Full Text] [Related]
3. [Clinical usefulness of DeltaMELD to predict the survival of patients with liver cirrhosis].
Eun SH; Kim YS; Jang JY; Cheon YG; Kim YS; Cho YD; Lee JS; Lee MS; Kim JH; Shim CS; Kim BS
Korean J Hepatol; 2006 Dec; 12(4):530-8. PubMed ID: 17237631
[TBL] [Abstract][Full Text] [Related]
4. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
Lv XH; Liu HB; Wang Y; Wang BY; Song M; Sun MJ
J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
[TBL] [Abstract][Full Text] [Related]
5. Model for end-stage liver disease, model for end-stage liver disease-sodium and Child-Turcotte-Pugh scores over time for the prediction of complications of liver cirrhosis.
Choi PC; Kim HJ; Choi WH; Park DI; Park JH; Cho YK; Sohn CI; Jeon WK; Kim BI
Liver Int; 2009 Feb; 29(2):221-6. PubMed ID: 18544124
[TBL] [Abstract][Full Text] [Related]
6. Proposal of a modified Child-Turcotte-Pugh scoring system and comparison with the model for end-stage liver disease for outcome prediction in patients with cirrhosis.
Huo TI; Lin HC; Wu JC; Lee FY; Hou MC; Lee PC; Chang FY; Lee SD
Liver Transpl; 2006 Jan; 12(1):65-71. PubMed ID: 16382473
[TBL] [Abstract][Full Text] [Related]
7. Can inclusion of serum creatinine values improve the Child-Turcotte-Pugh score and challenge the prognostic yield of the model for end-stage liver disease score in the short-term prognostic assessment of cirrhotic patients?
Giannini E; Botta F; Fumagalli A; Malfatti F; Testa E; Chiarbonello B; Polegato S; Bellotti M; Milazzo S; Borgonovo G; Testa R
Liver Int; 2004 Oct; 24(5):465-70. PubMed ID: 15482344
[TBL] [Abstract][Full Text] [Related]
8. Correlation and comparison of the model for end-stage liver disease, portal pressure, and serum sodium for outcome prediction in patients with liver cirrhosis.
Wang YW; Huo TI; Yang YY; Hou MC; Lee PC; Lin HC; Lee FY; Chi CW; Lee SD
J Clin Gastroenterol; 2007 Aug; 41(7):706-12. PubMed ID: 17667056
[TBL] [Abstract][Full Text] [Related]
9. Model for end-stage liver disease-sodium predicts prognosis in patients with chronic severe hepatitis B.
Cai CJ; Chen HA; Lu MQ; Chen GH
Chin Med J (Engl); 2008 Oct; 121(20):2065-9. PubMed ID: 19080277
[TBL] [Abstract][Full Text] [Related]
10. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
Huo TI; Lin HC; Hsia CY; Huang YH; Wu JC; Chiang JH; Chiou YY; Lui WY; Lee PC; Lee SD
Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
[TBL] [Abstract][Full Text] [Related]
11. Comparison of four model for end-stage liver disease-based prognostic systems for cirrhosis.
Huo TI; Lin HC; Huo SC; Lee PC; Wu JC; Lee FY; Hou MC; Lee SD
Liver Transpl; 2008 Jun; 14(6):837-44. PubMed ID: 18508377
[TBL] [Abstract][Full Text] [Related]
12. Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score.
Huo TI; Lin HC; Lee FY; Hou MC; Lee PC; Wu JC; Chang FY; Lee SD
Liver Int; 2006 Feb; 26(1):55-61. PubMed ID: 16420510
[TBL] [Abstract][Full Text] [Related]
13. Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acute-on-chronic hepatitis B liver failure.
Wang ZX; Yan LN; Wang WT; Xu MQ; Yang JY
Transplant Proc; 2007 Jun; 39(5):1501-4. PubMed ID: 17580172
[TBL] [Abstract][Full Text] [Related]
14. Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score.
Angermayr B; Luca A; König F; Bertolini G; Ploner M; Gridelli B; Ulbrich G; Reiberger T; Bosch J; Peck-Radosavljevic M
Eur J Clin Invest; 2009 Jan; 39(1):65-71. PubMed ID: 19087131
[TBL] [Abstract][Full Text] [Related]
15. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients.
Farnsworth N; Fagan SP; Berger DH; Awad SS
Am J Surg; 2004 Nov; 188(5):580-3. PubMed ID: 15546574
[TBL] [Abstract][Full Text] [Related]
16. Model for end stage liver disease score predicts mortality across a broad spectrum of liver disease.
Said A; Williams J; Holden J; Remington P; Gangnon R; Musat A; Lucey MR
J Hepatol; 2004 Jun; 40(6):897-903. PubMed ID: 15158328
[TBL] [Abstract][Full Text] [Related]
17. Elevated soluble tumor necrosis factor receptor 75 concentrations identify patients with liver cirrhosis at risk of death.
Grünhage F; Rezori B; Neef M; Lammert F; Sauerbruch T; Spengler U; Reichel C
Clin Gastroenterol Hepatol; 2008 Nov; 6(11):1255-62. PubMed ID: 18995216
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of the Model for End-stage Liver Disease and hepatic venous pressure gradient for predicting survival in patients with decompensated liver cirrhosis].
Lee SH; Park SH; Kim GW; Lee WJ; Hong WK; Ryu MS; Park KT; Lee MY; Lee CW; Kim JH; Kim YM; Kim SJ; Baik GH; Kim JB; Kim DJ
Korean J Hepatol; 2009 Sep; 15(3):350-6. PubMed ID: 19783884
[TBL] [Abstract][Full Text] [Related]
19. The safety of intra-abdominal surgery in patients with cirrhosis: model for end-stage liver disease score is superior to Child-Turcotte-Pugh classification in predicting outcome.
Befeler AS; Palmer DE; Hoffman M; Longo W; Solomon H; Di Bisceglie AM
Arch Surg; 2005 Jul; 140(7):650-4; discussion 655. PubMed ID: 16027329
[TBL] [Abstract][Full Text] [Related]
20. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
Giannini E; Botta F; Testa E; Romagnoli P; Polegato S; Malfatti F; Fumagalli A; Chiarbonello B; Risso D; Testa R
Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
